About this trial

This multi-center, prospective observational study aims to develop and validate an interpretable prediction model for Myocardial Injury After Noncardiac Surgery (MINS) in patients undergoing major hepatobiliary surgery. The study adopts a nested modeling strategy, starting with baseline risk factors (e.g., RCRI) and stepwise incorporating hepatic inflow occlusion strategies (specifically comparing SPVO vs. Pringle maneuver) and routine intraoperative biomarkers. The model's performance will be evaluated using AUC, Net Reclassification Improvement (NRI), and Decision Curve Analysis (DCA), followed by interpretability analysis using SHAP values and external validation in an independent cohort.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Major Hepatobiliary Surgery

Treatment groups

1,800 Participants
are divided into 2 treatment groups

Locations

6
Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine,Tsinghua University Beijing China
Peking University International Hospital Beijing China
The First Affiliated Hospital of Army Medical University Chongqing China
Qingdao West Coast New Area People's Hospital Qingdao China

Sponsors and collaborators

Beijing Tsinghua Chang Gung Hospital

Lead sponsor